Life science investor Novo Holdings, the venture capital arm of Novo Nordisk Foundation, is expanding into Asia and setting up an office in Singapore, the company said in a statement Thursday.
Novo Holdings said it has tapped Amit Kakar to head the Asian outpost and lead investments and partnerships in China, Japan, Singapore and the rest of Southeast Asia.
